Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill hopes to slow rare brain disease MSA

NCT ID NCT06568237

First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 40 times

Summary

This study tests an experimental oral drug, TEV-56286, in 350 adults with multiple system atrophy (MSA), a rare and progressive brain disorder. Participants will receive either the drug or a placebo for 48 weeks to see if it slows disease worsening and is safe. The goal is to find a treatment that helps control MSA symptoms and progression.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Teva Investigational Site 15543

    ACTIVE_NOT_RECRUITING

    Spokane, Washington, 99202, United States

  • Teva Investigational Site 15544

    ACTIVE_NOT_RECRUITING

    Boca Raton, Florida, 33486, United States

  • Teva Investigational Site 15545

    NOT_YET_RECRUITING

    Los Angeles, California, 90095, United States

  • Teva Investigational Site 15546

    ACTIVE_NOT_RECRUITING

    Kansas City, Kansas, 66160, United States

  • Teva Investigational Site 15547

    ACTIVE_NOT_RECRUITING

    Washington D.C., District of Columbia, 20007, United States

  • Teva Investigational Site 15548

    ACTIVE_NOT_RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

  • Teva Investigational Site 15549

    ACTIVE_NOT_RECRUITING

    New York, New York, 10016, United States

  • Teva Investigational Site 15550

    ACTIVE_NOT_RECRUITING

    Chicago, Illinois, 60612-3852, United States

  • Teva Investigational Site 15551

    ACTIVE_NOT_RECRUITING

    New York, New York, 10032-3726, United States

  • Teva Investigational Site 15552

    ACTIVE_NOT_RECRUITING

    Rochester, Minnesota, 55905, United States

  • Teva Investigational Site 15553

    ACTIVE_NOT_RECRUITING

    Durham, North Carolina, 27705-4410, United States

  • Teva Investigational Site 15554

    ACTIVE_NOT_RECRUITING

    La Jolla, California, 92037, United States

  • Teva Investigational Site 15555

    ACTIVE_NOT_RECRUITING

    Tampa, Florida, 33613, United States

  • Teva Investigational Site 15735

    NOT_YET_RECRUITING

    Hershey, Pennsylvania, 17033, United States

  • Teva Investigational Site 15736

    ACTIVE_NOT_RECRUITING

    Boston, Massachusetts, 02115, United States

  • Teva Investigational Site 15869

    NOT_YET_RECRUITING

    Georgetown, Texas, 78628, United States

  • Teva Investigational Site 15870

    NOT_YET_RECRUITING

    Farmington Hills, Michigan, 48334, United States

  • Teva Investigational Site 15873

    ACTIVE_NOT_RECRUITING

    Alexandria, Virginia, 22310, United States

  • Teva Investigational Site 15874

    RECRUITING

    Nashville, Tennessee, 37212, United States

  • Teva Investigational Site 30294

    ACTIVE_NOT_RECRUITING

    Padova, 35127, Italy

  • Teva Investigational Site 30295

    ACTIVE_NOT_RECRUITING

    Salerno, 84131, Italy

  • Teva Investigational Site 30296

    ACTIVE_NOT_RECRUITING

    Roma, 00163, Italy

  • Teva Investigational Site 30297

    ACTIVE_NOT_RECRUITING

    Catania, 95123, Italy

  • Teva Investigational Site 30298

    ACTIVE_NOT_RECRUITING

    Milan, 20132, Italy

  • Teva Investigational Site 30299

    ACTIVE_NOT_RECRUITING

    Bologna, 40139, Italy

  • Teva Investigational Site 31319

    ACTIVE_NOT_RECRUITING

    Valencia, 46026, Spain

  • Teva Investigational Site 31320

    ACTIVE_NOT_RECRUITING

    Pamplona, 31008, Spain

  • Teva Investigational Site 31321

    ACTIVE_NOT_RECRUITING

    Barcelona, 08036, Spain

  • Teva Investigational Site 31322

    ACTIVE_NOT_RECRUITING

    Seville, 41015, Spain

  • Teva Investigational Site 31323

    ACTIVE_NOT_RECRUITING

    Barcelona, 08035, Spain

  • Teva Investigational Site 31324

    ACTIVE_NOT_RECRUITING

    Barcelona, 08041, Spain

  • Teva Investigational Site 31327

    ACTIVE_NOT_RECRUITING

    Madrid, 28006, Spain

  • Teva Investigational Site 31328

    RECRUITING

    Barakaldo, 48903, Spain

  • Teva Investigational Site 31329

    RECRUITING

    Elche, 03203, Spain

  • Teva Investigational Site 31330

    RECRUITING

    Madrid, 28034, Spain

  • Teva Investigational Site 31331

    RECRUITING

    Madrid, 28041, Spain

  • Teva Investigational Site 32818

    ACTIVE_NOT_RECRUITING

    Dresden, 01307, Germany

  • Teva Investigational Site 32819

    ACTIVE_NOT_RECRUITING

    Münster, 48149, Germany

  • Teva Investigational Site 32820

    ACTIVE_NOT_RECRUITING

    München, 81377, Germany

  • Teva Investigational Site 32821

    ACTIVE_NOT_RECRUITING

    Ulm, 89081, Germany

  • Teva Investigational Site 32822

    ACTIVE_NOT_RECRUITING

    Düsseldorf, 40225, Germany

  • Teva Investigational Site 32823

    ACTIVE_NOT_RECRUITING

    Beelitz, 14547, Germany

  • Teva Investigational Site 32824

    ACTIVE_NOT_RECRUITING

    Marburg, 35033, Germany

  • Teva Investigational Site 32825

    ACTIVE_NOT_RECRUITING

    Kassel, 34128, Germany

  • Teva Investigational Site 32826

    RECRUITING

    Leipzig, 04103, Germany

  • Teva Investigational Site 35289

    ACTIVE_NOT_RECRUITING

    Marseille, 13385, France

  • Teva Investigational Site 35290

    ACTIVE_NOT_RECRUITING

    Bordeaux, 33400, France

  • Teva Investigational Site 35291

    ACTIVE_NOT_RECRUITING

    Paris, 75651 Cedex 13, France

  • Teva Investigational Site 35292

    ACTIVE_NOT_RECRUITING

    Toulouse, 31059, France

  • Teva Investigational Site 35300

    RECRUITING

    Caen, 14033, France

  • Teva Investigational Site 80203

    ACTIVE_NOT_RECRUITING

    Haifa, 31999, Israel

  • Teva Investigational Site 80204

    ACTIVE_NOT_RECRUITING

    Tel Aviv, 6423906, Israel

  • Teva Investigational Site 80215

    ACTIVE_NOT_RECRUITING

    Jerusalem, 9103102, Israel

  • Teva Investigational Site 84135

    ACTIVE_NOT_RECRUITING

    Sendai, 982-8555, Japan

  • Teva Investigational Site 84136

    ACTIVE_NOT_RECRUITING

    Gifu, 501-1112, Japan

  • Teva Investigational Site 84137

    ACTIVE_NOT_RECRUITING

    Niigata, 951-8520, Japan

  • Teva Investigational Site 84138

    ACTIVE_NOT_RECRUITING

    Sagamihara, 252-0392, Japan

  • Teva Investigational Site 84139

    ACTIVE_NOT_RECRUITING

    Fuchū, 183-0042, Japan

  • Teva Investigational Site 84140

    ACTIVE_NOT_RECRUITING

    Chiba, 260-8677, Japan

  • Teva Investigational Site 84141

    ACTIVE_NOT_RECRUITING

    Sanda-shi, 669-1592, Japan

Conditions

The condition(s) this trial relates to.

multiple system atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.